Novel Mechanism Of Chronic Exposure Of Oleic Acid-Induced Insulin Release Impairment In Rat Pancreatic β-Cells

Department

neurobiology

Document Type

Article

Abstract

A sustained, high circulating level of free fatty acids (FFAs) is an important risk factor for the development of insulin resistance, islet β-cell dysfunction, and pathogenesis of type 2 diabetes. Here, we report a novel mechanism of chronic exposure of oleic acid (OA)-induced rat insulin release impairment. Following a 4-day exposure to 0.1 mM OA, there was no significant difference in basal insulin release when comparing OA-treated and untreated islets in the presence of 2.8 mM glucose, whereas 16.7 mM glucose-stimulated insulin release increased 2-fold in control, but not in OA-treated, islets. Perforated patch-clamp recordings showed that untreated β-cells exhibited a resting potential of -62.1 ± 0.9 mV and were electrically silent, whereas OA-treated β-cells showed more positive resting potentials and spontaneous action potential firing. Cell-attached single-channel recordings revealed spontaneous opening of ATP-sensitive potassium (KATP) channels in control, but not in OA-treated, β-cells. Inside-out excised patch recordings showed similar activity in both OA-treated and untreated β-cells in the absence of ATP on the inside of the cellular membrane, whereas in the presence of ATP, KATP channel activity was significantly reduced in OA-treated β-cells. Electron microscopy demonstrated that chronic exposure to OA resulted in the accumulation of triglycerides in β-cell cytoplasm and reduced both the number of insulin-containing granules and insulin content. Collectively, chronic exposure to OA closed KATP channels by increasing the sensitivity of K ATP channels to ATP, which in turn led to the continuous excitation of β-cells, depletion of insulin storage, and impairment of glucose-stimulated insulin release. Copyright © 2006 by The American Society for Pharmacology and Experimental Therapeutics.

Publication Date

8-28-2006

Publication Title

Journal of Pharmacology and Experimental Therapeutics

ISSN

00223565

Volume

318

Issue

3

First Page

1203

Last Page

1210

Digital Object Identifier (DOI)

10.1124/jpet.106.105759

This document is currently not available here.

Share

COinS